Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Observational Study of Patients With Newly Diagnosed Unresectable Stage IIIB or IV Non-Small Cell Lung Cancer (NSCLC) in China

NCT02458651 is registered in ClinicalTrials.gov with Hoffmann-La Roche as lead sponsor.

NCT NCT02458651
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02458651 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Observational Study of Patients With Newly Diagnosed Unresectable Stage IIIB or IV Non-Small Cell Lung Cancer (NSCLC) in China
Lead sponsor
Hoffmann-La Roche
Phase
Observational
Overall status
Completed
Start date
June 26, 2015
Completion date
October 30, 2018
Enrollment
1,378 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

non-small cell lung cancer, lung cancer, cancer